Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study.

Landrum LM, Java J, Mathews CA, Lanneau GS, Copeland LJ, Armstrong DK, Walker JL. Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol. 2013 Jul; 130(1):12-8.

View in: PubMed

subject areas

Aged
Aged
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carboplatin
Cisplatin
Cisplatin
Cyclophosphamide
Cyclophosphamide
Disease-Free Survival
Disease-Free Survival
Female
Female
Humans
Humans
Infusions, Parenteral
Infusions, Parenteral
Lymphatic Metastasis
Lymphatic Metastasis
Middle Aged
Middle Aged
Multicenter Studies as Topic
Multicenter Studies as Topic
Multivariate Analysis
Multivariate Analysis
Neoplasm Staging
Neoplasm Staging
Neoplasm, Residual
Neoplasm, Residual
Neoplasms, Glandular and Epithelial
Neoplasms, Glandular and Epithelial
Ovarian Neoplasms
Ovarian Neoplasms
Paclitaxel
Paclitaxel
Prognosis
Prognosis
Randomized Controlled Trials as Topic
Randomized Controlled Trials as Topic
Retrospective Studies
Retrospective Studies
Survival Rate
Survival Rate

authors with profiles

Joan L Walker